Patients with unresectable metastatic disease are eligible for targeted therapies such as inhibitors of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) [3]. The gene discussed is VEGFA; the disease is metastatic neoplasm.